Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca

Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 2024 -- Cellectis a clinical-stage biotechnology...

Related Keywords

Paris ,France General ,France ,North Carolina ,United States ,New York ,Raleigh ,French ,Patricia Sosa Navarro ,Pascalyne Wilson ,Arthur Stril ,Ashleyr Robinson ,Marc Dunoyer ,Astrazeneca ,Nasdaq ,French Ministry Of Economy ,Euronext Growth ,French Ministry ,Additional Investment ,Tyrell Rivers ,Nasdaq Global Market ,Sosa Navarro ,Chief Business Officer ,Lifesci Advisors ,Markets ,